Eyebus SPRL
4.5 FTEThe score of Eyebus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +88 % Total assets +117 % Headcount (avg FTE) +36 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eyebus's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 126,708 € | ||||
| Equity | 515,121 € | ||||
| Cash | 25,728 € | ||||
| EBITDA | 399,967 € | ||||
| Total assets | €2.83m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 30 May 2024
- Year ended 31 Dec 2022filed on 01 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Eyebus's financial analysis
- Solvency18.2%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eyebus
Eyebus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0670.544.568
- VAT number
- BE0670544568
- Peppol
- Registered · 0208:0670544568 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 30 Jan 2017
- Registered office
- 1800 Vilvoorde
- Size
- Micro · 4.5 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of corrective glasses, lenses and sunglasses (NACE 47742)
Eyebus (SPRL) has been based in Vilvoorde since 2017, active in: retail sale of corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 126,708 € and equity of 515,121 €; its revenue is not published. With 4.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.2%, below the median of its sector (47.4%).
Companies similar to Eyebus
Companies in the same business, of comparable size and area, outside its group.
- PG Optics Retail sale of medical and orthopaedic goods Grimbergen · balance sheet €1.64m
- MiCa Assist Retail sale of medical and orthopaedic goods Londerzeel · balance sheet €1.63m
- Rembrandt Retail sale of medical and orthopaedic goods Antwerp · balance sheet €1.39m
- Optiek Weytjens Retail sale of medical and orthopaedic goods Asse · balance sheet €2.17m
- Opsin Optics Retail sale of medical and orthopaedic goods Uccle · balance sheet €2.03m
- Claeyssens Oog en Oor Retail sale of medical and orthopaedic goods Ghent · balance sheet €2.73m
- KALO Retail sale of medical and orthopaedic goods Aalter · balance sheet €2.98m
- Osiris - Daout Retail sale of medical and orthopaedic goods Verviers · balance sheet €2.63m
Frequently asked questions about Eyebus
What is the revenue of Eyebus?
Eyebus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eyebus?
In Belgium, the VAT number is the company number prefixed with BE: BE0670544568 for Eyebus, if the company is VAT-registered. Its company number (CBE) is 0670.544.568.
Where is the registered office of Eyebus?
According to the CBE register, the registered office of Eyebus is in 1800 Vilvoorde.
What is the equity of Eyebus?
At the close of the 2025 financial year, the equity of Eyebus amounts to 515,121 €, a solvency of 18.2% of total assets.
How many people work at Eyebus?
4.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Eyebus?
The register lists 1 active mandates at Eyebus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eyebus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →